BOTHE.BR Gross Margin

The Gross Margin of Bone Therapeutics SA (BOTHE.BR) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

BOTHE.BR Gross Margin - Peers Comparison

Ticker	Name	Value
MDXH.BR	MDxHealth SA	51.74%
ERYP.PA	Erytech Pharma SA	7775.20%
BML.WA	Synthaverse SA	55.44%
DNL.L	Diurnal Group PLC	78.16%
KAN.ST	Kancera AB	70.00%
OPTI.L	OptiBiotix Health PLC	49.69%
BIOPOR.CO	Bioporto A/S	67.68%
DEST.L	Destiny Pharma PLC	7775.20%
GLPG.AS	Galapagos NV	76.10%
TNG.PA	Transgene SA	-700.96%
COX.PA	Nicox SA	100.00%
OASM.ST	Oasmia Pharmaceutical AB	-6845.60%
OKYO.L	OKYO Pharma Ltd	7775.20%
CYXO.ST	Cyxone AB	100.00%
OXUR.BR	Oxurion NV	-1333.33%
PA8.DE	Paion AG	94.10%
ISOFOL.ST	Isofol Medical AB (publ)	-4773.23%
BIO.MC	Biosearch SA	39.64%
ALONX.PA	Onxeo SA	64.38%
ALPHA.PA	Pharnext SA	-14187.50%
ASIT.BR	DMS Imaging SA	25.00%
BONEH.HE	BBS-Bioactive Bone Substitutes Oyj	7775.20%
CYAD.BR	Celyad Oncology SA	93.55%
ACOU.ST	Acousort AB	-84.78%
B8F.DE	Biofrontera AG	80.64%
CIR.L	Circassia Group PLC	68.10%
ECX.DE	Epigenomics AG	75.26%
VICO.ST	Vicore Pharma Holding AB	197.14%
ADXN.SW	Addex Therapeutics Ltd	-958.33%